Jingting Jiang

17PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer cell biologyCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 09, 2025
IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.

Lujun Chen, Hongwei Jiang, Bo Tan

|Nov 10, 2025
Cancer-associated fibroblast-induced lncRNA WARS2-IT1 confers radioresistance of colorectal cancer via enhancing HIF-1α stability.

Yuanqi Li, Wei Dai, Xiao Zheng

|Sep 22, 2025
Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma.

Shuang Liu, Yihui Pan, Wenjian Liu

|Aug 25, 2025
Tumor-infiltrating CD103+CD8+hnRNPA2B1+ tissue-resident T cells indicate poor prognosis in patients with clear cell renal cell carcinoma.

Yingting Liu, Jiajin Ma, Bin Xu

|Oct 08, 2024
CX3CR1+CD8+ T cells: Key players in antitumor immunity.

Jiajin Ma, Yue Wu, Shaoxian Wu

|May 27, 2024
Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.

Ming Liu, Shaoxian Wu, Haoyu Wu

Pageof 3

Frequent Collaborators

4 joint publications

Yufang Shi

2 joint publications

You Zhou

2 joint publications

Xiao Zheng

2 joint publications

Gerry Melino